New strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts
- PMID: 20647474
- PMCID: PMC2932833
- DOI: 10.1158/1078-0432.CCR-09-1942
New strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts
Abstract
Pancreatic cancer (PC) is a highly lethal disease with complex etiology involving both environmental and genetic factors. Although cigarette smoking is known to explain 25% of cases, data from recent studies suggest that obesity and long-term type II diabetes are two major modifiable risk factors for PC. Furthermore, obesity and diabetes seem to affect the clinical outcome of patients with PC. Understanding the mechanistic effects of obesity and diabetes on the pancreas may identify new strategies for prevention or therapy. Experimental and epidemiologic evidence suggests that the antidiabetic drug metformin has protective antitumor activity in PC. In addition to insulin resistance and inflammation as mechanisms of carcinogenesis, obesity and diabetes are linked to impairments in endothelial function and coagulation status, which increase the risks of thrombosis and angiogenesis and, in turn, the risk of PC development and progression. The associations of the ABO blood group gene and NR5A2 gene variants with PC discovered by recent genome-wide association studies may link insulin resistance, inflammation, and thrombosis to pancreatic carcinogenesis. These exciting findings open new avenues for understanding the etiology of PC and provide opportunities for developing novel strategies for prevention and treatment of this disease.
Figures
Similar articles
-
The Impact of obesity and diabetes mellitus on pancreatic cancer: Molecular mechanisms and clinical perspectives.J Cell Mol Med. 2020 Jul;24(14):7706-7716. doi: 10.1111/jcmm.15413. Epub 2020 May 26. J Cell Mol Med. 2020. PMID: 32458441 Free PMC article. Review.
-
Diabetes and pancreatic cancer.Mol Carcinog. 2012 Jan;51(1):64-74. doi: 10.1002/mc.20771. Mol Carcinog. 2012. PMID: 22162232 Free PMC article.
-
Demographics, epidemiology, and inheritance of pancreatic ductal adenocarcinoma.Semin Oncol. 2015 Feb;42(1):8-18. doi: 10.1053/j.seminoncol.2014.12.002. Epub 2014 Dec 9. Semin Oncol. 2015. PMID: 25726048 Review.
-
Diabetes and pancreatic cancer.Endocr Relat Cancer. 2012 Sep 5;19(5):F9-F26. doi: 10.1530/ERC-12-0105. Print 2012 Oct. Endocr Relat Cancer. 2012. PMID: 22843556 Review.
-
[Diabetes and cancer risk: oncologic considerations].Orv Hetil. 2011 Jul 17;152(29):1144-55. doi: 10.1556/OH.2011.29158. Orv Hetil. 2011. PMID: 21712179 Review. Hungarian.
Cited by
-
Therapeutic effect of human iPS-cell-derived myeloid cells expressing IFN-β against peritoneally disseminated cancer in xenograft models.PLoS One. 2013 Jun 24;8(6):e67567. doi: 10.1371/journal.pone.0067567. Print 2013. PLoS One. 2013. PMID: 23826321 Free PMC article.
-
RhoT1 and Smad4 are correlated with lymph node metastasis and overall survival in pancreatic cancer.PLoS One. 2012;7(7):e42234. doi: 10.1371/journal.pone.0042234. Epub 2012 Jul 31. PLoS One. 2012. PMID: 22860091 Free PMC article.
-
Cancer risk in type 2 diabetes mellitus: metabolic links and therapeutic considerations.J Nutr Metab. 2011;2011:708183. doi: 10.1155/2011/708183. Epub 2011 Jun 1. J Nutr Metab. 2011. PMID: 21773024 Free PMC article.
-
Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling.Transl Oncol. 2013 Dec 1;6(6):649-59. doi: 10.1593/tlo.13556. eCollection 2013 Dec 1. Transl Oncol. 2013. PMID: 24466367 Free PMC article.
-
Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer.Free Radic Biol Med. 2011 Jun 1;50(11):1610-9. doi: 10.1016/j.freeradbiomed.2011.03.007. Epub 2011 Mar 12. Free Radic Biol Med. 2011. PMID: 21402145 Free PMC article.
References
-
- Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–249. - PubMed
-
- Anderson K, Mack T, Silverman D. Cancer of the Pancreas. In: Schottenfeld D, Fraumeni J, editors. Cancer Epidemiology and Prevention. Second ed. New York: Oxford; 2006. pp. 721–762.
-
- Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;8:579–591. - PubMed
-
- Larsson SC, Orsini N, Wolk A. Body mass index and pancreatic cancer risk: a meta-analysis of prospective studies. Int J Cancer. 2007;120:1993–1998. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical